Clioquinol's return: Cautions from Japan [3]

Science

Volumn 292, Issue 5525, 2001, Pages 2251-2252

  Tabira, T ^a   Bush, A I ^a   Masters, C L ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CLIOQUINOL; COPPER; SUPEROXIDE DISMUTASE; ZINC;

ALZHEIMER DISEASE; CHELATION; CLINICAL TRIAL; CYANOCOBALAMIN DEFICIENCY; DRUG SAFETY; HUMAN; JAPAN; LETTER; NERVE DEGENERATION; NONHUMAN; OPTIC TRACT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SPINAL CORD DORSAL HORN; SUBACUTE MYELOOPTIC NEUROPATHY;

ALZHEIMER DISEASE; ANIMALS; CLINICAL TRIALS, PHASE II; CLIOQUINOL; HUMANS; JAPAN; MICE; MYELITIS; OPTIC NEURITIS; SYNDROME; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 0035933550     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.292.5525.2251     Document Type: Letter

References (0)